PRODUCTS

  • > > Gastrointestinal System

    Imperan Injection

    English Name ：
    Imperan Injection
    R&D code ：
    AAD-094
    Product Licence  ：
    衛署藥製字第005896號
    NHI. NO. ：
    AC05896212
    Ingredients ：
    Metoclopramide 5 mg/mL
    Dosage Form ：
    Injection
    Strength ：
    2 mL
    包裝規格 ：
    50 A
    Marketing Status ：
    處方用藥
    Controlled Drugs ：
    NO
    Manufacturing Place ：
    Taiwan
    ATC Code ：
    A03FA01
    Indications  ：
    Relief of symptoms associated with acute and recurrent diabetic gastroparesis when oral treatment is not feasible. Prophylaxis of nausea/vomiting associated with emetogenic cancer chemotherapy. Prophylaxis of post-op nausea/vomiting in circumstances where nasogastric suction is undesirable.
    Dosage ：
    Diabetic gastroparesis (early manifestations): initiate with oral form; (severe symptoms): initiate with IM or IV inj. May give 10mg doses slowly by IV route over a 1–2 minute period. Administration up to 10 days may be needed, at which time oral form may be instituted. Prophylaxis of nausea/vomiting: administer by IV infusion slowly over at least 15mins; give 30mins before chemotherapy and repeat every 2hrs for 2 doses, then every 3hrs for 3 doses. If highly emetogenic drugs used alone or in combination (eg, cisplatin, dacarbazine): give 2mg/kg for initial 2 doses; if less emetogenic drugs: 1mg/kg per dose may suffice. For doses >10mg: dilute in 50mL of a parenteral soln. Prophylaxis of post-op nausea/vomiting: give by IM inj near the end of surgery. Usually 10mg, however, 20mg doses may be used.
    NHI. Price. ：
    15
    NHI. Effective Date ：
    100.12.01
    Licence Expire Day ：
    108/02/19
    Product Code ：
    4110002100942
產品資訊查詢:https://lmspiq.fda.gov.tw/web/DRPIQ/DRPIQ1000Result?licBaseId=6F99E4D8-3C3F-4931-B795-C41DDE386ED7
More
More Pro. Close Menu TOP